Business Description
Willow Biosciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA56087W2067
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.47 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -29.3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 38.1 | |||||
3-Year EPS without NRI Growth Rate | 19.8 | |||||
3-Year FCF Growth Rate | 17.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.87 | |||||
9-Day RSI | 32.36 | |||||
14-Day RSI | 37.24 | |||||
6-1 Month Momentum % | 12.5 | |||||
12-1 Month Momentum % | -21.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.3 | |||||
Quick Ratio | 2.18 | |||||
Cash Ratio | 1.75 | |||||
Days Sales Outstanding | 94.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | -9.22 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1152.73 | |||||
Net Margin % | -1111.69 | |||||
FCF Margin % | -984.47 | |||||
ROE % | -142.88 | |||||
ROA % | -112.2 | |||||
ROIC % | -381.41 | |||||
ROC (Joel Greenblatt) % | -466.24 | |||||
ROCE % | -131.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.44 | |||||
PB Ratio | 3.04 | |||||
Price-to-Tangible-Book | 3.04 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-EBITDA | -0.88 | |||||
EV-to-Revenue | 8.35 | |||||
EV-to-FCF | -0.85 | |||||
Price-to-Net-Current-Asset-Value | 8.5 | |||||
Earnings Yield (Greenblatt) % | -131.58 | |||||
FCF Yield % | -106.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Willow Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 1.172 | ||
EPS (TTM) (C$) | -0.1 | ||
Beta | 1.09 | ||
Volatility % | 62.24 | ||
14-Day RSI | 37.24 | ||
14-Day ATR (C$) | 0.003772 | ||
20-Day SMA (C$) | 0.09 | ||
12-1 Month Momentum % | -21.74 | ||
52-Week Range (C$) | 0.06 - 0.15 | ||
Shares Outstanding (Mil) | 126.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Willow Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Willow Biosciences Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Willow Biosciences Inc Frequently Asked Questions
What is Willow Biosciences Inc(TSX:WLLW)'s stock price today?
When is next earnings date of Willow Biosciences Inc(TSX:WLLW)?
Does Willow Biosciences Inc(TSX:WLLW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |